NAPLEX • PERSON-CENTERED ASSESSMENT AND TREATMENT PLANNING

Overdose And Exposure Management

A systematic approach to recognizing, stabilizing, and treating acute poisoning and drug overdose in clinical practice.

Historical Context & Motivation

The clinical management of poisoning and overdose has evolved dramatically from an era of largely empirical treatments to the evidence-based, algorithm-driven protocols pharmacists and clinicians rely on today. For centuries, practitioners had few options beyond inducing emesis or administering rudimentary antidotes with little understanding of pharmacokinetics or receptor pharmacology. The modern discipline of clinical toxicology emerged in the mid-twentieth century as a distinct specialty, catalyzed by an increasing number of pharmaceutical products on the market and a corresponding rise in both intentional and accidental overdose cases. Today, pharmacists occupy a pivotal role in overdose management — from recommending appropriate antidotes and decontamination strategies to monitoring for delayed toxicity and advising on enhanced elimination techniques.

1952
First Poison Control Center
The first Poison Control Center is established in Chicago, creating a centralized resource for managing toxic exposures and beginning the systematic cataloging of poisoning presentations and treatments.
1963
N-Acetylcysteine for Acetaminophen
Researchers identify N-acetylcysteine (NAC) as an effective antidote for acetaminophen hepatotoxicity, establishing one of the most important antidote–overdose pairings in clinical practice.
1971
Rumack-Matthew Nomogram
The Rumack-Matthew nomogram is developed, providing clinicians with a reliable tool to predict hepatotoxicity risk following acute acetaminophen ingestion based on serum concentration and time post-ingestion.
1997
Position Statements on Decontamination
The American Academy of Clinical Toxicology and the European Association of Poisons Centres issue joint position statements restricting the routine use of ipecac syrup and gastric lavage, favoring activated charcoal as the primary decontamination strategy when indicated.
2015–Present
Naloxone Access Expansion
In response to the opioid crisis, naloxone is made available over-the-counter and via pharmacist-dispensed protocols in most U.S. states, positioning pharmacists as frontline providers in opioid overdose reversal and harm reduction.

Despite these advances, poisoning remains a leading cause of injury-related morbidity and mortality. The U.S. Poison Control system fields over 2 million calls annually, and drug overdose deaths — driven largely by synthetic opioids — have exceeded 100,000 per year in recent tallies. The central question that overdose and exposure management seeks to address is: How can clinicians rapidly identify the offending agent, stabilize the patient, and deploy targeted interventions to reverse or mitigate toxicity? This lesson equips you with the systematic framework needed to answer that question on the NAPLEX and in clinical practice.

Core Principles of Overdose Management

Effective overdose management follows a structured, stepwise approach that prioritizes life-threatening conditions before addressing specific toxicological concerns. The overarching framework can be distilled into five foundational principles that guide assessment and treatment regardless of the substance involved. Understanding these principles ensures that pharmacists can contribute meaningfully to the interdisciplinary team managing an acutely poisoned patient, whether the encounter occurs in the emergency department, inpatient ward, or community setting.

1

Stabilize (ABCs First)

Before any toxicological intervention, ensure airway patency, adequate breathing, and circulatory stability. Airway, Breathing, Circulation (ABCs) take absolute priority, including intubation, IV access, and vasopressors as needed.
2

Identify the Toxidrome

A toxidrome is a constellation of signs and symptoms that suggests a particular class of poisoning — for example, miosis, respiratory depression, and CNS depression indicate opioid toxicity. Pattern recognition accelerates diagnosis.
3

Decontaminate When Appropriate

Gastrointestinal decontamination (primarily activated charcoal) may reduce systemic absorption if administered within 1–2 hours of ingestion. The decision depends on the substance, timing, and patient's airway status.
4

Administer Specific Antidotes

When a specific antidote exists (e.g., naloxone for opioids, flumazenil for benzodiazepines, NAC for acetaminophen), it should be deployed promptly. Not every overdose has a reversal agent; supportive care is the mainstay in many cases.
5

Enhance Elimination & Monitor

Techniques such as urinary alkalinization, hemodialysis, and multi-dose activated charcoal can hasten drug removal. Continuous monitoring for delayed toxicity (e.g., acetaminophen hepatotoxicity) is essential.
KEY TAKEAWAY
Think of overdose management like responding to a house fire. First, ensure everyone can breathe and escape safely (ABCs). Then identify the type of fire — electrical, chemical, or structural (toxidrome identification). Next, choose the right extinguisher for the fire type (antidote selection). Finally, manage the aftermath and prevent re-ignition (enhanced elimination and monitoring). Skipping steps or using the wrong tool can worsen the situation.

Overdose Management Algorithm — Visual Overview

The algorithm progresses from stabilization (Step 1, top) through identification, decontamination, antidote administration, and enhanced elimination (Step 5, bottom). Annotations on either side indicate specific interventions associated with each step. Continuous monitoring spans the entire process.

The diagram above illustrates the sequential nature of overdose management while emphasizing that monitoring and reassessment are continuous, not relegated to a single final step. In clinical reality, some steps may overlap — for example, an antidote such as naloxone may be administered empirically during initial stabilization before a complete toxidrome assessment is finished, particularly when opioid overdose is strongly suspected based on respiratory depression and miosis. The key insight is that the algorithm provides a mental scaffold: even in a high-acuity scenario, working through each step systematically prevents omission of critical interventions.

Toxidromes & Antidote Mechanisms

Major Toxidromes in Clinical Practice

A toxidrome is a recognizable pattern of signs and symptoms produced by a class of toxic substances. Memorizing the hallmark features of the five major toxidromes is essential for rapid clinical decision-making, as laboratory confirmation of the offending agent often takes hours while management decisions must be made in minutes. The five classic toxidromes are the opioid, sympathomimetic, anticholinergic, cholinergic, and sedative-hypnotic toxidromes.

Major Toxidromes and Their Corresponding Antidotes
ToxidromeKey Signs & SymptomsCausative AgentsAntidote / Reversal
OpioidMiosis, respiratory depression, CNS depression, ↓ bowel sounds, bradycardiaMorphine, fentanyl, heroin, oxycodone, methadoneNaloxone (competitive μ-receptor antagonist)
SympathomimeticMydriasis, tachycardia, hypertension, hyperthermia, diaphoresis, agitationCocaine, amphetamines, MDMA, pseudoephedrineBenzodiazepines (supportive); avoid β-blockers in cocaine
AnticholinergicMydriasis, dry skin/mouth, tachycardia, urinary retention, delirium, hyperthermiaDiphenhydramine, atropine, TCAs, scopolaminePhysostigmine (AChE inhibitor — use cautiously)
CholinergicSLUDGE/BBB: Salivation, Lacrimation, Urination, Defecation, GI distress, Emesis; Bradycardia, Bronchospasm, BronchorrheaOrganophosphates, carbamates, nerve agentsAtropine + pralidoxime (2-PAM)
Sedative-HypnoticCNS depression, respiratory depression, hypotension, hypothermia, normal/small pupilsBenzodiazepines, barbiturates, ethanol, zolpidemFlumazenil (BZD antagonist — risk of seizures)

Antidote Mechanisms of Action

Antidotes work through several distinct pharmacological mechanisms. Competitive antagonism — exemplified by naloxone at μ-opioid receptors — directly displaces the offending agent from its binding site. Chelation agents like succimer (DMSA) bind heavy metals to form excretable complexes. Metabolic diversion is the strategy behind NAC, which replenishes glutathione stores and provides an alternative substrate for the toxic metabolite NAPQI in acetaminophen overdose. Enzyme reactivation describes how pralidoxime regenerates acetylcholinesterase bound by organophosphates, but only before irreversible "aging" of the enzyme occurs. Understanding these mechanisms guides dosing strategies, repeat dosing intervals, and anticipated timelines for clinical improvement.

💡 Clinical Pearl
Naloxone's duration of action (30–90 minutes) is often shorter than the duration of action of the opioid causing the overdose (especially methadone or sustained-release formulations). Patients who respond to naloxone must be monitored for recurrent respiratory depression and may require repeat dosing or a continuous infusion (typically two-thirds of the effective bolus dose per hour).

Antidote Compendium & Decontamination Strategies

High-Yield Antidote Reference

High-Yield Antidote Reference for NAPLEX Preparation
Poison / OverdoseAntidoteKey Dosing / Notes
AcetaminophenN-Acetylcysteine (NAC)IV: 150 mg/kg over 1 h → 50 mg/kg over 4 h → 100 mg/kg over 16 h. PO: 140 mg/kg load → 70 mg/kg q4h × 17 doses. Most effective within 8–10 h.
OpioidsNaloxone0.04–2 mg IV/IM/SC/IN; titrate to respiratory effort. May repeat q2–3 min. Consider infusion for long-acting opioids.
BenzodiazepinesFlumazenil0.2 mg IV over 30 sec; may repeat 0.3–0.5 mg q1 min (max 3–5 mg). Contraindicated in chronic BZD use, co-ingestion of pro-convulsant agents.
Warfarin / Vitamin K antagonistVitamin K₁ (phytonadione)10 mg IV slow infusion for serious bleeding; PO for non-urgent. 4-factor PCC for life-threatening hemorrhage.
OrganophosphatesAtropine + PralidoximeAtropine 2–4 mg IV q5–10 min until secretions dry. Pralidoxime 1–2 g IV over 15–30 min; must give before enzyme aging.
DigoxinDigoxin-specific Fab antibodiesDose based on amount ingested or steady-state level. Each vial binds ~0.5 mg digoxin.
Methanol / Ethylene glycolFomepizole (4-MP)15 mg/kg IV load → 10 mg/kg q12h × 4 doses → 15 mg/kg q12h. Inhibits alcohol dehydrogenase. Hemodialysis often needed.
IronDeferoxamine15 mg/kg/h IV infusion (max 6 g/day). Indicated when serum iron > 500 mcg/dL or signs of systemic toxicity.
Beta-blocker / CCBGlucagon / High-dose insulin (HIE)Glucagon 3–10 mg IV; HIE: insulin 1 unit/kg bolus + 1–10 units/kg/h infusion with dextrose and K⁺ monitoring.
This decision tree guides clinicians through the GI decontamination assessment. The key branch points are airway protection, time since ingestion, and whether the substance is adsorbed by activated charcoal. The PHAILS mnemonic at the bottom identifies agents for which activated charcoal is ineffective.

Gastrointestinal decontamination has undergone significant refinement over the past two decades. Ipecac syrup is no longer recommended in any clinical setting due to risk of aspiration and lack of efficacy data. Gastric lavage is reserved for life-threatening ingestions presenting within one hour and is rarely performed. Single-dose activated charcoal (SDAC) at 1 g/kg (maximum 50 g in adults) remains the preferred method when indicated, though its benefit diminishes rapidly beyond one to two hours post-ingestion. Whole bowel irrigation (WBI) with polyethylene glycol electrolyte solution is considered for sustained-release formulations, iron, lithium, and body packers. Multi-dose activated charcoal (MDAC) enhances elimination of drugs with enterohepatic or enteroenteric recirculation, including theophylline, carbamazepine, dapsone, and phenobarbital.

Worked Example — Acute Acetaminophen Overdose

A 22-year-old female presents to the emergency department reporting she ingested approximately 50 tablets of extra-strength acetaminophen (500 mg each) approximately 4 hours ago in a suicide attempt. She weighs 60 kg. She is alert and oriented, and her vitals are stable. The serum acetaminophen level drawn at 4 hours post-ingestion is 250 mcg/mL. The pharmacist is consulted to guide the management plan.

Acetaminophen Overdose — Step-by-Step Management
1
Step 1 — Assess the ABCs and StabilizeThe patient's airway is intact, she is breathing spontaneously, and her circulation is stable. No immediate resuscitative measures are required. IV access is established, and baseline labs are drawn (hepatic panel, renal function, coagulation studies, serum acetaminophen level, salicylate level).
Patient stable — proceed to assessment.
2
Step 2 — Estimate the Ingested DoseTotal reported ingestion: 50 tablets × 500 mg = 25,000 mg (25 g). On a mg/kg basis: 25,000 mg ÷ 60 kg ≈ 417 mg/kg. A single acute ingestion exceeding 150 mg/kg or 7.5 g (whichever is less) in a healthy adult is considered potentially toxic and warrants treatment with NAC.
417 mg/kg — well above the 150 mg/kg toxicity threshold
3
Step 3 — Plot on the Rumack-Matthew NomogramAt 4 hours post-ingestion, a serum acetaminophen level of 250 mcg/mL is plotted on the Rumack-Matthew nomogram. The treatment line begins at 150 mcg/mL at 4 hours. Since 250 mcg/mL exceeds 150 mcg/mL, the patient falls above the treatment line, confirming the need for NAC therapy.
Above treatment line → NAC indicated
4
Step 4 — Consider GI DecontaminationAt 4 hours post-ingestion, the benefit of activated charcoal is significantly diminished, as peak absorption of acetaminophen typically occurs within 1–2 hours of standard-release formulation ingestion. Charcoal may be considered but is unlikely to provide substantial benefit at this time point. The clinician elects to forgo charcoal and proceed directly with antidote therapy.
Activated charcoal deferred (>2 hours post-ingestion)
5
Step 5 — Initiate IV NAC ProtocolThe standard 21-hour IV NAC protocol is initiated. Bag 1: 150 mg/kg × 60 kg = 9,000 mg in 200 mL D5W over 1 hour. Bag 2: 50 mg/kg × 60 kg = 3,000 mg in 500 mL D5W over 4 hours. Bag 3: 100 mg/kg × 60 kg = 6,000 mg in 1,000 mL D5W over 16 hours. The patient is monitored for anaphylactoid reactions (flushing, urticaria, bronchospasm), which are common during the loading dose.
NAC loading dose: 9,000 mg (150 mg/kg) IV over 1 hour
6
Step 6 — Monitor and ReassessRepeat hepatic function tests (AST, ALT), INR, creatinine, and serum acetaminophen level are obtained at the conclusion of the NAC infusion and serially as indicated. If transaminases are rising or the acetaminophen level remains detectable, the NAC infusion is continued beyond 21 hours. The patient should also receive a psychiatric evaluation prior to discharge given the intentional nature of the ingestion.
Continue NAC until APAP undetectable, AST/ALT trending down, INR < 2.0

Strengths & Limitations of Common Interventions

Comparison of Major Overdose Management Interventions
InterventionStrengthsLimitations / Risks
Activated Charcoal (SDAC)Broad adsorption spectrum; noninvasive; can be given orally or via NG tube; well-studiedNarrow time window (≤1–2 h); aspiration risk; does not adsorb metals, lithium, alcohols; patient compliance issues
NaloxoneRapid onset (1–2 min IV); available IM, SC, IN; OTC availability; high therapeutic indexShort duration vs. long-acting opioids; may precipitate withdrawal; re-sedation risk
NAC (for APAP)Near 100% hepatoprotection if given ≤8 h; IV and PO formulations; well-characterized dosingAnaphylactoid reactions (IV route); nausea/vomiting (PO route); extended protocols (21–72 h)
FlumazenilRapid reversal of BZD sedation; diagnostic utilitySeizure risk in chronic BZD users and co-ingestion with proconvulsants; short duration; rarely indicated in acute OD
HemodialysisEffective for small, water-soluble, low-protein-bound molecules (methanol, ethylene glycol, lithium, salicylates); corrects acid-base abnormalitiesInvasive; requires vascular access; not effective for highly protein-bound or large Vd drugs; resource-intensive
Urinary AlkalinizationNoninvasive; enhances renal elimination of weak acids (salicylates, methotrexate, phenobarbital)Requires close monitoring of urine pH, serum K⁺, fluid balance; ineffective for non-renally cleared substances
KEY TAKEAWAY
No single intervention is universally effective for all overdoses — the pharmacist's value lies in matching the right tool to the right toxicological scenario. Think of the intervention toolkit like a surgical tray: the scalpel (specific antidote) is ideal when you know the pathology, but sometimes you need the sponge (supportive care) while you figure it out. The most dangerous mistake is reaching for a reversal agent reflexively — for example, giving flumazenil to a patient with unknown co-ingestants risks precipitating life-threatening seizures.

Advanced Topics & Emerging Therapies

As the landscape of substance misuse and pharmaceutical innovation evolves, so too do the challenges and tools of overdose management. Several advanced topics merit attention for students preparing for NAPLEX and clinical rotations, as these areas represent the frontier of toxicology practice.

Standard vs. Advanced/Emerging Approaches in Toxicology
Standard ApproachAdvanced / Emerging Approach
Naloxone bolus dosing for opioid ODNalmefene (longer-acting antagonist) for fentanyl analogs; high-dose naloxone protocols for novel synthetic opioids resistant to standard dosing
20% Intralipid emulsion for local anesthetic toxicity onlyIntravenous lipid emulsion (ILE) therapy now considered for lipophilic drug overdoses (CCBs, TCAs, beta-blockers) as a 'lipid sink'
Sodium bicarbonate for TCA-induced QRS wideningHypertonic saline under investigation as adjunct; recognition of Brugada-pattern ECG changes from sodium channel blockade expanding indications
Dantrolene for malignant hyperthermiaCyproheptadine for serotonin syndrome; targeted cooling protocols for sympathomimetic/MDMA hyperthermia
Poison control phone consultationTelemedicine toxicology consults; AI-assisted toxidrome identification; real-time mass spectrometry for unknown substance identification

One particularly important advanced concept is the use of high-dose insulin euglycemia (HIE) therapy for severe calcium channel blocker and beta-blocker poisoning. Traditional vasopressor therapy often fails in these cases because the toxicity is fundamentally metabolic — the myocardium is "starved" of glucose substrate due to impaired insulin-mediated glucose uptake. HIE addresses this by flooding the myocardium with insulin (1 unit/kg bolus followed by 1–10 units/kg/h infusion) while maintaining euglycemia with dextrose and monitoring potassium closely. This represents a paradigm shift from purely hemodynamic support to metabolic resuscitation.

📋 NAPLEX Focus
The NAPLEX may test your ability to recognize when standard antidotes are insufficient and advanced therapies are warranted. Key scenarios include: fentanyl overdoses requiring higher or repeated naloxone dosing, TCA overdoses requiring sodium bicarbonate when QRS > 100 ms, and CCB overdoses where vasopressors fail and HIE therapy or ILE is indicated. Always remember that Poison Control (1-800-222-1222) is a resource available 24/7 and its use is considered standard of care.

Practice Problems

PROBLEM 1CONCEPTUAL
A patient presents with miosis, respiratory depression, decreased level of consciousness, and bradycardia. Which toxidrome does this presentation most closely match, and what is the first-line pharmacological intervention?
PROBLEM 2BASIC CALCULATION
A 70 kg adult presents after an acute acetaminophen ingestion estimated at 14 g. Calculate the mg/kg dose ingested and determine whether this exceeds the toxicity threshold. If the 4-hour serum acetaminophen level is 180 mcg/mL, is NAC indicated per the Rumack-Matthew nomogram?
PROBLEM 3INTERMEDIATE
A patient presents 30 minutes after ingesting an unknown quantity of sustained-release verapamil. The patient is hemodynamically stable at this time. Activated charcoal has been administered. Over the next two hours, the patient develops progressive hypotension (BP 70/40 mmHg) and bradycardia (HR 35 bpm) refractory to IV calcium gluconate and atropine. What pharmacological strategy should the pharmacist recommend next?
PROBLEM 4APPLIED
A community pharmacist dispenses naloxone to the caregiver of a patient on chronic high-dose methadone (120 mg daily). The caregiver asks: "Why did you give me two doses? Isn't one enough?" Provide a pharmacologically sound explanation the pharmacist should offer.
PROBLEM 5CRITICAL THINKING
A 45-year-old male presents to the ED with altered mental status, tachycardia (HR 130 bpm), mydriasis, dry flushed skin, urinary retention, and temperature of 39.2°C. His wife reports he may have taken "several" of his amitriptyline tablets (a tricyclic antidepressant). The ECG shows a QRS duration of 120 ms. Differentiate the overlapping toxidromes present, and outline the complete pharmacist-recommended management plan, including any agents that are specifically contraindicated.

Overdose & Exposure Management — Summary

Overdose and exposure management is built on a systematic five-step framework: stabilize the ABCs, identify the toxidrome (opioid, sympathomimetic, anticholinergic, cholinergic, or sedative-hypnotic), decontaminate when appropriate (activated charcoal within 1–2 hours; remember PHAILS for substances charcoal does not adsorb), administer the specific antidote (naloxone for opioids, NAC for acetaminophen, atropine plus pralidoxime for organophosphates, fomepizole for toxic alcohols, digoxin-specific Fab for digoxin), and enhance elimination and monitor continuously (hemodialysis, urinary alkalinization, MDAC, serial labs).

Critical clinical pearls to carry forward: naloxone's short duration necessitates prolonged monitoring after long-acting opioid overdoses; flumazenil is contraindicated in chronic benzodiazepine users and TCA co-ingestions; the Rumack-Matthew nomogram guides NAC therapy decisions in acute acetaminophen overdose; sodium bicarbonate is the cornerstone of TCA cardiac toxicity management; and high-dose insulin euglycemia therapy is indicated for refractory calcium channel blocker and beta-blocker poisoning. Always contact Poison Control (1-800-222-1222) — it is a standard-of-care resource for both community and institutional pharmacists.

Varsity Tutors • NAPLEX • Overdose And Exposure Management